Clareo Health | Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
EMD Serono
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Prior enrollment into selected oral cladribine clinical trials as of randomization to either study drug or placebo, once participation in the clinical trial has ended
Written informed consent was given
You may not be if
Participants who cannot be reached by telephone
Participants unable to answer the registry questionnaires and who do not have a next of kin or caregiver able to answer the registry questionnaires
Participants who - either during the lag interval or subsequently enter an interventional study
